ONE游戏官网

Brief News | Chairman Shi Yuanyuan Attends Shenzhen Biomedicine and Big Health Special Seminar and Delivers Lecture to Municipal Department Officials

Date:06-08  Hits:  Belong to:News

  On June 7, 2023, our Chairman, Professor Shi Yuanyuan, was invited to attend the Shenzhen Biomedicine and Big Health Special Seminar, organized by the Organization Department of the Shenzhen Municipal Party Committee and the Organization Department of the Pingshan District Committee. He served as a lecturer, delivering a lecture to over forty bureau-, division-, and section-level leading officials from relevant municipal departments. The lecture was moderated by Professor Fang Shenying from the School of Public Health and Emergency Management at the Southern University of Science and Technology School of Medicine.

图片

In his lecture, Professor Shi Yuanyuan provided a detailed introduction to the current status and progress of cell therapy both internationally and domestically, the development of stem cell and immune cell applications, the characteristics and pain points of various cell therapies, and relevant national and local regulations. He also provided a comprehensive introduction to Shenzhen Cell Valley's development history, construction goals, core technologies, and strategic positioning. The lecture lasted over three hours, with students actively interacting and showing great enthusiasm, concluding successfully in an atmosphere of lingering interest.


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@loteriass.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Cell Valley Group is a leading CGT infrastructure platform in China. We capitalize on the strategic window opened by Decree No. 818 to bridge the gap between clinical research and commercialization.

We pioneer the "Hospital to Industry" (H2I) model. Basically, we act as the core partner for hospitals, providing a one-stop solution for new biomedical tech—covering process development, GMP manufacturing, QC, and commercial rollout. Our mission is to push China's CGT sector from pure R&D into a standardized, scalable industry.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software